Daily
250 words
6/10
Rating

25 August 2026

Rare disease patient data

The topic discusses a specific proposed governance model (Patient Data Collective) and its integration with existing national digital health infrastructure, which is highly relevant to GS2 governance and welfare policy questions.

1 min read 2 questions 2 prelims

Notes

  • Rare diseases require patient data for diagnostic biomarkers, disease progression modeling, and clinical trial design.
  • Conventional clinical trials are often unfeasible for rare diseases due to small participant pools and the inability to form control groups.
  • Natural-history studies and patient registries provide real-world data that act as 'external' controls for drug evaluation.
  • The proposed 'Patient Data Collective' (PDC) is a cooperative model inspired by Amul, designed to aggregate patient records from hospitals, advocacy groups, and the Ayushman Bharat Digital Health Mission.
  • The PDC would function as a secure, patient-centric repository with AI-based analytics to facilitate drug discovery and regulatory approval.
  • The ICMR currently maintains a rare disease registry covering approximately 4,000 patients across 19 specialized hospitals.
  • India's New Drugs and Clinical Trials Rules now permit advanced computational modeling and non-animal testing, supporting the use of synthetic control groups.
  • Generative AI can be used to synthesize medical patterns and engage patients in local languages, improving data inclusivity.
  • Aggregating data from India's genetically diverse, endogamous populations may attract international drug developers seeking specific target-validation cohorts.

Questions

  1. Discuss the potential of a 'Patient Data Collective' model in addressing the challenges of clinical trials for rare diseases in India. 150 words
    Attempt this — 150 words in 8 min
    0 / 150 words 8:00
  2. How can the integration of digital health infrastructure and artificial intelligence facilitate the development of orphan drugs? Examine the ethical and governance challenges in creating a centralized patient data repository. 250 words
    Attempt this — 250 words in 11 min
    0 / 250 words 11:00

Prelims

  1. Which of the following best describes the role of 'natural-history studies' in the context of rare disease research?

  2. The 'Patient Data Collective' (PDC) model proposed for India draws inspiration from which organizational structure?